GLENMARK expands in the US! ππ
GLENMARK US arm acquires and launches Acetylcysteine Injection, a generic version of Acetadote, boosting its hospital care portfolio.
The $15.2M market entry strengthens Glenmarkβs global presence in generics and specialty medicines across 50+ countries!
#StockInNews#WatchOutFor
281 likesΒ·63 comments

















